申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2012109080A1
公开(公告)日:2012-08-16
The present disclosure relates to compounds of formula I, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
本公开涉及公式I的化合物,用于治疗丙型肝炎病毒(HCV)感染的组合物和方法。还披露了含有这些化合物的药物组合物以及使用这些化合物治疗HCV感染的方法。